Thymocyte development is normal in CTLA-4-deficient mice
- PMID: 9256476
- PMCID: PMC23164
- DOI: 10.1073/pnas.94.17.9296
Thymocyte development is normal in CTLA-4-deficient mice
Abstract
Recent studies indicate that CTLA-4 interaction with B7 ligands transduces an inhibitory signal to T lymphocytes. Mice homozygous for a null mutation in CTLA-4 have provided the most dramatic example of the functional importance of CTLA-4 in vivo. These animals develop a fatal lymphoproliferative disorder and were reported to have an increase in CD4(+) and CD8(+) thymocytes and CD4(-)CD8(-) thymocytes, and a decrease in CD4(+)CD8(+) thymocytes. Based on these observations, it was proposed that CTLA-4 is necessary for normal thymocyte development. In this study, CTLA-4-deficient mice carrying an insertional mutation into exon 3 of the ctla-4 gene were generated. Although these mice display a lymphoproliferative disorder similar to previous reports, there was no alteration in the thymocyte profiles when the parathymic lymph nodes were excluded from the thymi. Further, thymocyte development was normal throughout ontogeny and in neonates, and there was no increase in thymocyte production. Finally, T cell antigen receptor signaling, as assessed by proximal and distal events, was not altered in thymocytes from CTLA-4(-/-) animals. Collectively, these results clearly demonstrate that the abnormal T cell expansion in the CTLA-4-deficient mice is not due to altered thymocyte development and suggest that the apparent altered thymic phenotype previously described was due to the inclusion of parathymic lymph nodes and, in visibly ill animals, to the infiltration of the thymus by activated peripheral T cells. Thus it appears that CTLA-4 is primarily involved in the regulation of peripheral T cell activation.
Figures





Similar articles
-
Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells.Immunity. 1997 Dec;7(6):885-95. doi: 10.1016/s1074-7613(00)80406-9. Immunity. 1997. PMID: 9430233
-
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses.Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8603-8. doi: 10.1073/pnas.96.15.8603. Proc Natl Acad Sci U S A. 1999. PMID: 10411922 Free PMC article.
-
The role of B7 costimulation in CD4/CD8 T cell homeostasis.J Immunol. 2000 Apr 1;164(7):3543-53. doi: 10.4049/jimmunol.164.7.3543. J Immunol. 2000. PMID: 10725709
-
CTLA-4 and T cell activation.Curr Opin Immunol. 1999 Jun;11(3):294-300. doi: 10.1016/s0952-7915(99)80047-8. Curr Opin Immunol. 1999. PMID: 10375557 Review.
-
The Yin and Yang of T cell costimulation.Science. 1995 Nov 10;270(5238):932-3. doi: 10.1126/science.270.5238.932. Science. 1995. PMID: 7481795 Review. No abstract available.
Cited by
-
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells.Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12711-6. doi: 10.1073/pnas.220423597. Proc Natl Acad Sci U S A. 2000. PMID: 11050166 Free PMC article.
-
Induction of cytotoxic T lymphocyte antigen 4 (CTLA-4) restricts clonal expansion of helper T cells.J Exp Med. 2001 Oct 1;194(7):893-902. doi: 10.1084/jem.194.7.893. J Exp Med. 2001. PMID: 11581312 Free PMC article.
-
Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein.Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9273-8. doi: 10.1073/pnas.94.17.9273. Proc Natl Acad Sci U S A. 1997. PMID: 9256472 Free PMC article.
-
Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4.Gut. 2015 Dec;64(12):1889-97. doi: 10.1136/gutjnl-2014-308541. Epub 2014 Nov 3. Gut. 2015. PMID: 25367873 Free PMC article.
-
A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention.Cancer Discov. 2021 Mar;11(3):614-625. doi: 10.1158/2159-8290.CD-20-0856. Epub 2020 Nov 30. Cancer Discov. 2021. PMID: 33257470 Free PMC article.
References
-
- Lenschow D J, Walunas T L, Bluestone J A. Annu Rev Immunol. 1996;14:233–258. - PubMed
-
- Chambers C A, Krummel M F, Boitel B, Hurwitz A A, Sullivan T J, Fournier S, Cassell D, Brunner M, Allison J P. Immunol Rev. 1996;153:27–46. - PubMed
-
- Walunas T L, Lenschow D J, Bakker C Y, Linsley P S, Freeman G J, Green J M, Thompson C B, Bluestone J A. Immunity. 1994;1:405–413. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials